Technical Analysis for AYTU - Aytu BioScience, Inc.

Grade Last Price % Change Price Change
C 2.89 0.70% 0.02
AYTU closed up 0.7 percent on Monday, March 18, 2024, on 2.97 times normal volume. It was able to find support at its 50 day moving average.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Support Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Gapped Down Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.70%
Inside Day Range Contraction 0.70%
Fell Below 20 DMA Bearish 0.70%

   Recent Intraday Alerts

Alert Time
Rose Above 20 DMA about 13 hours ago
60 Minute Opening Range Breakout about 13 hours ago
Rose Above 10 DMA about 13 hours ago
Possible Pocket Pivot about 13 hours ago
Reversed from Up about 14 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aytu BioScience, Inc. Description

Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Alcohol Prostate Cancer Urology In Vitro Hormones Fertility Ketones Estrogen Imaging Agent Infertility Testosterone Urinary Tract Infection In Vitro Diagnostic Device Androstanes Company's Pipeline Male Infertility Urinary Tract Infections

Is AYTU a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.5
52 Week Low 1.38
Average Volume 20,982
200-Day Moving Average 2.35
50-Day Moving Average 2.84
20-Day Moving Average 3.00
10-Day Moving Average 3.02
Average True Range 0.19
RSI (14) 46.52
ADX 19.36
+DI 23.27
-DI 18.23
Chandelier Exit (Long, 3 ATRs) 2.88
Chandelier Exit (Short, 3 ATRs) 3.33
Upper Bollinger Bands 3.22
Lower Bollinger Band 2.77
Percent B (%b) 0.27
BandWidth 15.24
MACD Line 0.03
MACD Signal Line 0.05
MACD Histogram -0.0265
Fundamentals Value
Market Cap 16.09 Million
Num Shares 5.57 Million
EPS -6.31
Price-to-Earnings (P/E) Ratio -0.46
Price-to-Sales 0.16
Price-to-Book 0.50
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.43
Resistance 3 (R3) 3.47 3.32 3.34
Resistance 2 (R2) 3.32 3.19 3.31 3.31
Resistance 1 (R1) 3.11 3.10 3.22 3.07 3.28
Pivot Point 2.96 2.96 3.02 2.95 2.96
Support 1 (S1) 2.75 2.83 2.86 2.71 2.50
Support 2 (S2) 2.60 2.74 2.59 2.47
Support 3 (S3) 2.39 2.60 2.44
Support 4 (S4) 2.35